Proficio Capital Partners LLC Takes Position in CVS Health Corporation $CVS

Proficio Capital Partners LLC acquired a new position in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 10,072 shares of the pharmacy operator’s stock, valued at approximately $1,042,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CVS. Caitong International Asset Management Co. Ltd grew its position in CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 281 shares during the period. Swiss RE Ltd. acquired a new position in CVS Health during the fourth quarter worth $26,000. Kilter Group LLC purchased a new stake in CVS Health during the second quarter worth $27,000. Sankala Group LLC purchased a new position in shares of CVS Health in the fourth quarter valued at $28,000. Finally, Global Trust Asset Management LLC increased its position in shares of CVS Health by 344.8% in the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 300 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on CVS. Argus lifted their target price on shares of CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a research report on Wednesday, August 19th. UBS Group upped their target price on CVS Health from $122.00 to $126.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Truist Financial upped their price objective on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Wall Street Zen raised CVS Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. Finally, Mizuho upped their target price on shares of CVS Health from $110.00 to $115.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Twenty-two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Stock Performance

CVS Health stock opened at $94.22 on Thursday. The stock has a fifty day moving average price of $101.63 and a 200 day moving average price of $89.33. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The firm has a market capitalization of $120.50 billion, a P/E ratio of 24.93, a PEG ratio of 0.84 and a beta of 0.61. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same period last year, the company earned $1.81 EPS. The firm’s quarterly revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health’s dividend payout ratio is 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.